Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022)
Zimmer Biomet Holdings (ZBH) recorded quarterly Notes Payables of $83.0 million in Q4 2022, up 16500.0% quarter-over-quarter from $500000.0 in Q4 2013.
Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022) Analysis & Trends
Zimmer Biomet Holdings' Notes Payables history runs 4 years deep, the most recent figure standing at $83.0 million for Q4 2022.
- In Q4 2022, Notes Payables changed N/A year-over-year to $83.0 million; the TTM figure through Dec 2022 stood at $83.0 million (changed N/A YoY), while the FY2022 annual figure was $83.0 million, changed N/A from the prior year.
- Notes Payables was $83.0 million for Q4 2022 at Zimmer Biomet Holdings, up from $500000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $83.0 million in Q4 2022 to a low of $83.0 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 83.00 Mn |
| Dec 31, 2013 | 500,000.00 |
| Dec 31, 2012 | 100.10 Mn |
| Sep 30, 2012 | 300,000.00 |
| Jun 30, 2012 | 3.40 Mn |
| Mar 31, 2012 | 144.60 Mn |
| Dec 31, 2011 | 143.30 Mn |